Cheang, M C U <br/><br/>
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES.  [electronic resource] 

 -  Breast cancer research and treatment  Feb 2018 
 - 169-178 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-017-4543-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androstadienes--pharmacology<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Breast--pathology<br/>Breast Neoplasms--mortality<br/>Chemotherapy, Adjuvant--methods<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Mastectomy<br/>Middle Aged<br/>Neoplasm Recurrence, Local--epidemiology<br/>Prognosis<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Tamoxifen--pharmacology<br/>Time Factors